Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Spir

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

63 API Suppliers, 16 USDMF, 12 CEP/COS, 2 JDMF, 9 EU WC, 2 KDMF, 15 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

63 Drugs in Development

63 Drugs in Development

FINISHED DOSAGE FORMULATIONS

393 FDF Dossiers, 16 FDA Orange Book, 302 Europe, 7 Canada, 18 Australia, 15 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY, AEROSOL, METERED;NASAL - 0.04MG/ACTUATION, AEROSOL, METERED;NASAL - 0.08MG/ACTUATION, AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Gloria Interchem, 1 Ideal Cures, 2 Kerry, 2 Keval Exports, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 8 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 15 Solubilizers, 15 Thickeners and Stabilizers, 9 Parenteral, 9 Direct Compression, 8 Co-Processed Excipients, 5 Disintegrants & Superdisintegrants, 5 Granulation, 5 Controlled & Modified Release, 4 Coating Systems & Additives, 4 Film Formers & Plasticizers, 4 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 3 Taste Masking, 3 Surfactant & Foaming Agents, 3 Topical, 3 Emulsifying Agents, 1 API Stability Enhancers, 1 Lubricants & Glidants

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 21 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 60 Regulatory FDF Prices, 4 Annual Reports

MARKET PLACE

13 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

44 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/03/2026	Sicor Societa Italiana Corticosteroidi Srl	Italy	Sicor Societa (') Italiana Corticosteroidi S. r. l.	218MF10532	Beclomethasone propionate (Teva)	2006-06-01	2006-06-01	Piazzale Luigi Cadorna, 4-20123 MILANO, Italy
31/03/2026	Sicor Societa Italiana Corticosteroidi Srl	Italy	Sicor Societa (') Italiana Corticosteroidi S. r. l.	218MF10626	Beclomethasone propionate "Teva/Low"	2006-07-20	2006-07-20	Piazzale Luigi Cadorna, 4-20123 MILANO, Italy

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Spir

Spir

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

63 API Suppliers

16 USDMF

12 CEP/COS

2 JDMF

9 EU WC

2 KDMF

15 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

63 Drugs in Development

FINISHED DOSAGE FORMULATIONS

393 FDF Dossiers

16 FDA Orange Book

302 Europe

7 Canada

18 Australia

15 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

2 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Kirsch Pharma

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Gloria Interchem

1 Ideal Cures

2 Kerry

2 Keval Exports

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 Silverline Chemicals

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

15 Solubilizers

15 Thickeners and Stabilizers

9 Parenteral

9 Direct Compression

8 Co-Processed Excipients

5 Disintegrants & Superdisintegrants

5 Granulation

5 Controlled & Modified Release

4 Coating Systems & Additives

4 Film Formers & Plasticizers

4 Rheology Modifiers

4 Chewable & Orodispersible Aids

3 Taste Masking

3 Surfactant & Foaming Agents

3 Topical

3 Emulsifying Agents

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons